» Articles » PMID: 29224246

Circadian Peak Dopaminergic Activity Response at the Biological Clock Pacemaker (suprachiasmatic Nucleus) Area Mediates the Metabolic Responsiveness to a High-fat Diet

Overview
Specialty Endocrinology
Date 2017 Dec 11
PMID 29224246
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Among vertebrate species of the major vertebrate classes in the wild, a seasonal rhythm of whole body fuel metabolism, oscillating from a lean to obese condition, is a common biological phenomenon. This annual cycle is driven in part by annual changes in the circadian dopaminergic signalling at the suprachiasmatic nuclei (SCN), with diminution of circadian peak dopaminergic activity at the SCN facilitating development of the seasonal obese insulin-resistant condition. The present study investigated whether such an ancient circadian dopamine-SCN activity system for expression of the seasonal obese, insulin-resistant phenotype may be operative in animals made obese amd insulin resistant by high-fat feeding and, if so, whether reinstatement of the circadian dopaminergic peak at the SCN would be sufficient to reverse the adverse metabolic impact of the high-fat diet without any alteration of caloric intake. First, we identified the supramammillary nucleus as a novel site providing the majority of dopaminergic neuronal input to the SCN. We further identified dopamine D2 receptors within the peri-SCN region as being functional in mediating SCN responsiveness to local dopamine. In lean, insulin-sensitive rats, the peak in the circadian rhythm of dopamine release at the peri-SCN coincided with the daily peak in SCN electrophysiological responsiveness to local dopamine administration. However, in rats made obese and insulin resistant by high-fat diet (HFD) feeding, these coincident circadian peak activities were both markedly attenuated or abolished. Reinstatement of the circadian peak in dopamine level at the peri-SCN by its appropriate circadian-timed daily microinjection to this area (but not outside this circadian time-interval) abrogated the obese, insulin-resistant condition without altering the consumption of the HFD. These findings suggest that the circadian peak of dopaminergic activity at the peri-SCN/SCN is a key modulator of metabolism and the responsiveness to adverse metabolic consequences of HFD consumption.

Citing Articles

Tyrosine Hydroxylase Knockdown at the Hypothalamic Supramammillary Nucleus Area Induces Obesity and Glucose Intolerance.

Zhang Y, Tsai T, Ezrokhi M, Stoelzel C, Cincotta A Neuroendocrinology. 2023; 114(5):483-510.

PMID: 38128505 PMC: 11098027. DOI: 10.1159/000535944.


Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.

Cincotta A Int J Mol Sci. 2023; 24(17).

PMID: 37686060 PMC: 10487918. DOI: 10.3390/ijms241713255.


Circadian Dysfunction in Adipose Tissue: Chronotherapy in Metabolic Diseases.

Civelek E, Ozturk Civelek D, Akyel Y, Kaleli Durman D, Okyar A Biology (Basel). 2023; 12(8).

PMID: 37626963 PMC: 10452180. DOI: 10.3390/biology12081077.


The interplay between prolactin and cardiovascular disease.

Glezer A, Santana M, Bronstein M, Donato Jr J, Jallad R Front Endocrinol (Lausanne). 2023; 13:1018090.

PMID: 36704037 PMC: 9871591. DOI: 10.3389/fendo.2022.1018090.


Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.

Cincotta A, Cersosimo E, Alatrach M, Ezrokhi M, Agyin C, Adams J Int J Mol Sci. 2022; 23(16).

PMID: 36012132 PMC: 9407769. DOI: 10.3390/ijms23168851.


References
1.
Meguid M, Fetissov S, Varma M, Sato T, Zhang L, Laviano A . Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition. 2000; 16(10):843-57. DOI: 10.1016/s0899-9007(00)00449-4. View

2.
Rada P, Bocarsly M, Barson J, Hoebel B, Leibowitz S . Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet. Physiol Behav. 2010; 101(3):394-400. PMC: 2930885. DOI: 10.1016/j.physbeh.2010.07.005. View

3.
Wilson J, Meier A . Resetting the annual cycle with timed daily injections of 5-hydroxytryptophan and L-dihydroxyphenylalanine in Syrian hamsters. Chronobiol Int. 1989; 6(2):113-21. DOI: 10.3109/07420528909064621. View

4.
Yazici D, Sezer H . Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol. 2017; 960:277-304. DOI: 10.1007/978-3-319-48382-5_12. View

5.
Sleipness E, Sorg B, Jansen H . Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: dependence on the suprachiasmatic nucleus. Brain Res. 2006; 1129(1):34-42. DOI: 10.1016/j.brainres.2006.10.063. View